Gene · 7012
Papers4,156
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,156
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Midsize noncoding RNAs in cancers: a new division that clarifies the world of noncoding RNA or an unnecessary chaos? | Rep Pract Oncol Radiother | 2022 | 36632289 | PubTator, text mining | PubMed |
| Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies. | Int J Mol Sci | 2022 | 36614156 | PubTator, text mining | PubMed |
| Interstitial Lung Disease in Immunocompromised Children. | Diagnostics (Basel) | 2022 | 36611354 | PubTator, text mining | PubMed |
| Modern aspects of the management of pancreatic intraductal papillary mucinous neoplasms: a narrative review. | Rom J Morphol Embryol | 2022 | 36588487 | PubTator, text mining | PubMed |
| Two mutations in the SBDS gene reveal a diagnosis of Shwachman-Diamond syndrome in a patient with atypical symptoms. | Cold Spring Harb Mol Case Stud | 2022 | 36577524 | PubTator, text mining | PubMed |
| Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients. | Metabolites | 2022 | 36557263 | PubTator, text mining | PubMed |
| Impacts of Telomeric Length, Chronic Hypoxia, Senescence, and Senescence-Associated Secretory Phenotype on the Development of Thoracic Aortic Aneurysm. | Int J Mol Sci | 2022 | 36555139 | PubTator, text mining | PubMed |
| The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review. | Diagnostics (Basel) | 2022 | 36553114 | PubTator, text mining | PubMed |
| Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective. | Diagnostics (Basel) | 2022 | 36552935 | PubTator, text mining | PubMed |
| Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study). | Biomedicines | 2022 | 36552047 | PubTator, text mining | PubMed |
| Whole Genome Sequencing (WGS) Analysis of Virulence and AMR Genes in Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli from Animal and Environmental Samples in Four Italian Swine Farms. | Antibiotics (Basel) | 2022 | 36551431 | PubTator, text mining | PubMed |
| Epitranscriptomics in parasitic protists: Role of RNA chemical modifications in posttranscriptional gene regulation. | PLoS Pathog | 2022 | 36548245 | PubTator, text mining | PubMed |
| DNA-enabled fluorescent-based nanosensors monitoring tumor-related RNA toward advanced cancer diagnosis: A review. | Front Bioeng Biotechnol | 2022 | 36532593 | PubTator, text mining | PubMed |
Mobile colistin resistance (MCR), extended-spectrum beta-lactamase (ESBL) and multidrug resistance monitoring in Escherichia coli (commensal and pathogenic) in pig farming: need of harmonized guidelines and clinical breakpoints. | Front Microbiol | 2022 | 36532469 | PubTator, text mining | PubMed |
| Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. | Signal Transduct Target Ther | 2022 | 36522308 | PubTator, text mining | PubMed |
| Many Functions of Telomerase Components: Certainties, Doubts, and Inconsistencies. | Int J Mol Sci | 2022 | 36499514 | PubTator, text mining | PubMed |
| Idiopathic Pulmonary Fibrosis and Telomeres. | J Clin Med | 2022 | 36498467 | PubTator, text mining | PubMed |
| Ten Years of CRISPRing Cancers In Vitro. | Cancers (Basel) | 2022 | 36497228 | PubTator, text mining | PubMed |
| LncRNA/miRNA/mRNA Network Introduces Novel Biomarkers in Prostate Cancer. | Cells | 2022 | 36497036 | PubTator, text mining | PubMed |
| Novel TINF2 gene mutation in dyskeratosis congenita with extremely short telomeres: A case report. | World J Clin Cases | 2022 | 36483815 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7012/papers?page=26